ABOUT GENOPTIX

WHO WE ARE

Genoptix is one of the largest hematopathology centers in the U.S. and is a leading clinical oncology laboratory specializing in hematology and solid tumors. Located in Carlsbad, California, with a staff of over 400, and occupying over 27,000 square feet of laboratory space, Genoptix’s modern facilities are well-suited to handle the large volume of samples that enters its doors each day.

WHAT WE DO

Genoptix provides personalized and comprehensive diagnostic services to hematologists, oncologists and pathologists, with a specialization in diagnosing cancers and disorders in bone marrow, blood, and lymph nodes, as well as in molecular testing of solid tumors. Through an integrated approach to case management, Genoptix delivers individualized, actionable results for each patient to help the referring physician make the best treatment decisions.

OUR VISION

At Genoptix, our vision is to be the world leader in specialized cancer diagnostics, providing definite answers that improve patients’ lives.

OUR MISSION

We create significant value for the patient and the healthcare system by transforming diagnostic information into actionable clinical insights and by empowering the global oncology community.

OUR LEADERSHIP TEAM

MANAGEMENT TEAM

Joseph M. Limber
Chief Executive Officer and President

Mark E. Spring
Chief Financial Officer

Brett K.E. Lund, JD, MBA
Chief Legal Officer and General Counsel

Derek Lyle, MD, FCAP
Chief Medical Officer and Medical Director

Frederick A. Fletcher, PhD
Senior Vice President, Lab Operations

Juan Estruch
Head of Corporate Development

Mike Skinner
Chief Information Officer

BOARD OF DIRECTORS

Joseph M. Limber
Genoptix, Inc.

Herbert H. Hooper
Ampersand Capital Partners

Eric B. Lev
Ampersand Capital Partners

Adele Oliva
1315 Capital, LP

Frank Witney

Paul Touhey

Laurence R. McCarthy

OUR MEDICAL EXPERTS

Genoptix provides access to one of the largest teams of board-certified experts in one location to ensure accurate, insightful, and timely diagnoses for even the most challenging cases.

PRODUCT & SERVICE HIGHLIGHTS

TEST PORTFOLIO

Most advanced offerings of molecular diagnostic testing solutions, plus morphology, flow cytometry and cytogenetics

FULL SERVICE NGS LAB

Genoptix is a leader in commercial-scale next-gen sequencing; with over 48,000 samples accessioned since Jan 2012

CHANNEL STRENGTH

Trusted clinical partner serving oncologists and pathologists with dedicated customer service, expert lab specialists, and medical pathology team

Contact us

1 + 6 = ?

INFORMATION

Genoptix is located in Carlsbad, California.

HEADQUARTERS 
Genoptix, 2131 Faraday Ave., Carlsbad, CA 92008

LABORATORY  
Genoptix, 2110 Rutherford Road, Carlsbad, CA 92008

SEND PAYMENTS TO
Genoptix, PO Box 644828, Pittsburgh, PA 15264-4828

BUSINESS PHONE
Phone: +1.760.268.6200 Fax: +1.760.268.6201

CLIENT SERVICES
Phone:+1.800.755.1605
Email: clientservices@genoptix.com

BILLING
Phone: +1.800.755.0802
Email: billing@genoptix.com

CONFERENCES

Genoptix will be exhibiting at the following medical conferences:

NCCN 12th Annual Congress: Hematologic Malignancies 2017
San Francisco, CA
October 6-7, 2017
Learn more: https://www.nccn.org/professionals/meetings/hematological/default.aspx

AMP 2017
Association Molecular Pathologists Annual Meeting
Salt Lake City, UT
November 16-18, 2017
Booth # 1800
Learn more: http://amp17.amp.org/

ASH 2017
American Society of Hematology Annual Meeting
Atlanta, GA
December 9-12, 2017
Booth # 502
Learn more: http://www.hematology.org/Annual-Meeting/

NCCN 23rd Annual Conference 2018
National Comprehensive Cancer Network
Improving the Quality, Effectiveness, and Efficiency of Cancer Care
Orlando, FL
March 22-24, 2018
Learn more: https://www.nccn.org/

ASCO 2018
American Society of Clinical Oncology Annual Meeting
Chicago, IL
June 1-5, 2018
Learn more: http://am.asco.org

NCCN 13th Annual Congress: Hematologic Malignancies 2018
National Comprehensive Cancer Network
October 2018
Learn more: https://www.nccn.org/